Table 3.
Optimal laboratory measurements associated with lowest risk of macrovascular complication
| N | A1C | LDL-C | SBP | DBP | |||||
| Estimate | SD | Estimate | SD | Estimate | SD | Estimate | SD | ||
| Whole population | 124 651 | 6.76 | 0.24 | 111.65 | 6.78 | 130.6 | 6.64 | Negative linear | |
| Subgroup | |||||||||
| Age | |||||||||
| <50 | 15 819 | 6.96 | 0.23 | Positive linear | 121.1 | 4.75 | Negative linear | ||
| (50,60) | 36 539 | 6.8 | 0.23 | 124.25 | 9.83 | 124.2 | 5.11 | Negative linear | |
| (60, 70) | 47 867 | 6.71 | 0.19 | 131.55 | 8.49 | 136.95 | 6.62 | Negative linear | |
| (70,80) | 24 426 | 6.56 | 0.27 | 104.6 | 6.46 | 134.3 | 6.11 | Negative linear | |
| Race | |||||||||
| White | 84 028 | 6.67 | 0.22 | 130.05 | 8.42 | 138.85 | 5.77 | Negative linear | |
| Black | 24 817 | 6.96 | 0.24 | 119.8 | 9.02 | 122.95 | 5.02 | Negative linear | |
| Others | 4673 | 8.57 | 1.13 | 104.1 | 7.23 | Positive linear | Negative linear | ||
| BMI | |||||||||
| <25 | 30 084 | 6.64 | 0.28 | 108.5 | 5.84 | 113.15 | 6.73 | Negative linear | |
| (25,30) | 24 989 | 6.43 | 0.25 | 132.5 | 9.44 | 123.5 | 4.63 | Negative linear | |
| ≥30 | 69 578 | 6.85 | 0.22 | 114.75 | 7.47 | 148.35 | 6.71 | Negative linear | |
BMI, body mass index; DBP, diastolic blood pressure; LDL-C, low-density lipoprotein cholesterol; SBP, systolic blood pressure.